| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 49.79▼ | 49.78▲ | 49.77▲ | 50.26▼ | 50.13▼ |
| MA10 | 49.78▲ | 50.09▼ | 50.14▼ | 50.13▼ | 49.79▼ |
| MA20 | 50.10▼ | 50.07▼ | 50.06▼ | 50.09▼ | 49.35▲ |
| MA50 | 50.04▼ | 50.03▼ | 49.93▼ | 49.76▲ | 47.18▲ |
| MA100 | 49.76▲ | 49.68▲ | 49.65▲ | 49.22▲ | 45.55▲ |
| MA200 | 48.97▲ | 48.57▲ | 48.36▲ | 47.50▲ | 42.60▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.049▼ | -0.076▼ | -0.073▼ | -0.038▼ | -0.041▼ |
| RSI | 40.510▼ | 41.550▼ | 42.678▼ | 47.084▼ | 58.402▲ |
| STOCH | 34.674 | 5.618▼ | 20.974 | 68.237 | 83.782▲ |
| WILL %R | -92.135▼ | -92.135▼ | -90.110▼ | -86.124▼ | -38.808 |
| CCI | -44.395 | -73.659 | -70.286 | -104.377▼ | 23.562 |
|
Monday, December 01, 2025 03:59 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Wednesday, October 12, 2022 12:01 AM
- Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across four dose cohorts in the nine treated patients in the dose escalation phase. - All nine patients exhibited ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 49.73 | 49.80 | 49.73 | 49.79 | 21,843 |
| 29/12/25 | 49.77 | 49.77 | 49.659 | 49.74 | 10,755 |
| 26/12/25 | 50.67 | 50.69 | 50.60 | 50.65 | 6,230 |
| 24/12/25 | 50.54 | 50.6187 | 50.54 | 50.61 | 9,917 |
| 23/12/25 | 50.405 | 50.52 | 50.4033 | 50.50 | 4,218 |
| 22/12/25 | 50.275 | 50.36 | 50.24 | 50.36 | 16,854 |
| 19/12/25 | 50.14 | 50.1999 | 50.10 | 50.1108 | 9,468 |
| 18/12/25 | 49.89 | 50.08 | 49.8826 | 49.91 | 8,423 |
| 17/12/25 | 49.87 | 50.00 | 49.645 | 49.66 | 20,721 |
| 16/12/25 | 50.01 | 50.01 | 49.79 | 49.94 | 50,586 |
|
|
||||
|
|
||||
|
|